Literature DB >> 21664370

Cytotoxicity and genotoxicity of chitooligosaccharides upon lymphocytes.

Joao C Fernandes1, Margarida Borges, Henrique Nascimento, Elsa Bronze-da-Rocha, Oscar S Ramos, Manuela E Pintado, F Xavier Malcata, Alice Santos-Silva.   

Abstract

Two COS mixtures and a low molecular weight chitosan (LMWC) were tested for potential cytotoxicity and genotoxicity upon human lymphocytes. Genotoxicity was evaluated in vitro by cytokinesis-blocked micronucleus and alkaline comet assays, while cytotoxicity was assessed by flow cytometry analysis. Our results suggest that COS do not exhibit any genotoxicity upon human lymphocytes, independently of MW or concentration. However, above 0.07mg/mL COS induced strong cytotoxic effects. According to the concentration used, such cytotoxicity will induce cell death, essentially by necrosis (>0.10mg/mL) and/or apoptosis (<0.10mg/mL). The level of necrosis/apoptosis induced by high COS concentrations, suggests a promising use as apoptosis inducers in specific cancer situations.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664370     DOI: 10.1016/j.ijbiomac.2011.05.032

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  4 in total

1.  Biocompatibility of chitosan carriers with application in drug delivery.

Authors:  Susana Rodrigues; Marita Dionísio; Carmen Remuñán López; Ana Grenha
Journal:  J Funct Biomater       Date:  2012-09-17

2.  Transcutaneous treatment with vetdrop(®) sustains the adjacent cartilage in a microfracturing joint defect model in sheep.

Authors:  M Sidler; N Fouché; I Meth; F von Hahn; B von Rechenberg; Pw Kronen
Journal:  Open Orthop J       Date:  2013-03-05

3.  Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule.

Authors:  Joana Soares; Liliana Raimundo; Nuno A L Pereira; Ângelo Monteiro; Sara Gomes; Cláudia Bessa; Clara Pereira; Glória Queiroz; Alessandra Bisio; João Fernandes; Célia Gomes; Flávio Reis; Jorge Gonçalves; Alberto Inga; Maria M M Santos; Lucília Saraiva
Journal:  Oncotarget       Date:  2016-01-26

Review 4.  The Role of Chitosan Oligosaccharide in Metabolic Syndrome: A Review of Possible Mechanisms.

Authors:  Wenjing Tao; Geng Wang; Jintao Wei
Journal:  Mar Drugs       Date:  2021-09-01       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.